SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-323222
Filing Date
2021-11-08
Accepted
2021-11-08 17:25:35
Documents
15
Period of Report
2021-11-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d233598d8k.htm   iXBRL 8-K 33623
2 EX-1.1 d233598dex11.htm EX-1.1 183059
3 EX-5.1 d233598dex51.htm EX-5.1 51429
7 GRAPHIC g233598g1105092522498.jpg GRAPHIC 1561
  Complete submission text file 0001193125-21-323222.txt   456223

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mrus-20211104.xsd EX-101.SCH 2879
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrus-20211104_lab.xml EX-101.LAB 18054
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrus-20211104_pre.xml EX-101.PRE 11372
8 EXTRACTED XBRL INSTANCE DOCUMENT d233598d8k_htm.xml XML 3383
Mailing Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM
Business Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM 31 030 253 8800
Merus N.V. (Filer) CIK: 0001651311 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37773 | Film No.: 211389010
SIC: 2834 Pharmaceutical Preparations